Midatech Pharma Stock Price, News & Analysis (NASDAQ:MTP)

$1.08 0.03 (2.86 %)
(As of 12/11/2017 07:58 AM ET)
Previous Close$1.05
Today's Range$1.04 - $1.16
52-Week Range$1.00 - $3.65
Volume7,700 shs
Average Volume12,598 shs
Market Capitalization$32.99 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.46

About Midatech Pharma (NASDAQ:MTP)

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.

Receive MTP News and Ratings via Email

Sign-up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MTP
CUSIPN/A
Phone44-0-12-3588-8300

Debt

Debt-to-Equity Ratio0.03%
Current Ratio1.62%
Quick Ratio1.49%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.38 million
Price / Sales3.52
Cash FlowN/A
Price / CashN/A
Book Value$2.54 per share
Price / Book0.43

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees79
Outstanding Shares30,540,000

Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

Who are some of Midatech Pharma's key competitors?

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the folowing people:

  • James Neil Phillips, Chief Executive Officer, Director
  • Nicholas John Robbins-Cherry, Finance Director, Director (Age 45)
  • Craig Cook, Chief Operating Officer / Chief Medical Officer
  • Daniel David Palmer Ph.D., Chief Scientific Officer
  • Justin Barry, Head - Manufacturing
  • Tim Sparey, Chief Business Officer
  • Rolf Stahel, Non-Executive Chairman of the Board (Age 72)
  • Simon De Vries, Non-Executive Director (Age 56)
  • John Joseph Johnston, Non-Executive Director
  • Michele Luzi, Non-Executive Director (Age 57)

How do I buy Midatech Pharma stock?

Shares of Midatech Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Midatech Pharma's stock price today?

One share of Midatech Pharma stock can currently be purchased for approximately $1.08.

How big of a company is Midatech Pharma?

Midatech Pharma has a market capitalization of $32.99 million and generates $9.38 million in revenue each year. Midatech Pharma employs 79 workers across the globe.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is 65 INNOVATION DRIVE MILTON PARK, ABINGDON X0, OX14 4RQ. The company can be reached via phone at 44-0-12-3588-8300 or via email at [email protected]


MarketBeat Community Rating for Midatech Pharma (MTP)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Midatech Pharma (NASDAQ:MTP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/ABuy
Consensus Rating Score: N/AN/AN/A3.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$388.00
Price Target Upside: N/AN/AN/A7,085.19% upside

Midatech Pharma (NASDAQ:MTP) Consensus Price Target History

Price Target History for Midatech Pharma (NASDAQ:MTP)

Midatech Pharma (NASDAQ:MTP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/6/2016N+1 SingerReiterated RatingBuy$385.00 -> $300.00N/AView Rating Details
1/4/2016Panmure GordonReiterated RatingBuy$476.00N/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Earnings History for Midatech Pharma (NASDAQ:MTP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Midatech Pharma (NASDAQ:MTP) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171($0.08)($0.08)($0.08)
Q4 20171($0.09)($0.09)($0.09)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Midatech Pharma (NASDAQ:MTP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Midatech Pharma (NASDAQ MTP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Midatech Pharma (NASDAQ MTP) News Headlines

Source:
DateHeadline
European ADRs Advance as Banks Log GainsEuropean ADRs Advance as Banks Log Gains
www.nasdaq.com - December 9 at 9:50 AM
Midatech Pharma PLC (MTP) to Post Q3 2017 Earnings of ($0.08) Per Share, Zacks Investment Research ForecastsMidatech Pharma PLC (MTP) to Post Q3 2017 Earnings of ($0.08) Per Share, Zacks Investment Research Forecasts
www.americanbankingnews.com - November 30 at 5:58 AM
Initiating Coverage of Midatech Pharma (MTP); Novel Nanotechnology Platforms Focused on Oncology and Other Therapeutic AreasInitiating Coverage of Midatech Pharma (MTP); Novel Nanotechnology Platforms Focused on Oncology and Other Therapeutic Areas
finance.yahoo.com - November 27 at 4:53 PM
Midatech Pharma Plc: Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegalyMidatech Pharma Plc: Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly
feeds.benzinga.com - September 4 at 7:55 AM
European ADRs Fractionally Higher Despite Banking ContractionsEuropean ADRs Fractionally Higher Despite Banking Contractions
www.nasdaq.com - June 1 at 7:33 PM
European ADRs Fractionally Higher as Banking Stocks Edge ForwardEuropean ADRs Fractionally Higher as Banking Stocks Edge Forward
www.nasdaq.com - May 1 at 5:40 PM
European ADRs Fractionally Higher as Banking Stocks Edge ForwardEuropean ADRs Fractionally Higher as Banking Stocks Edge Forward
www.nasdaq.com - May 1 at 5:40 PM
European ADRs Edge Higher as Pharmaceutical Stocks See Mixed FortunesEuropean ADRs Edge Higher as Pharmaceutical Stocks See Mixed Fortunes
www.nasdaq.com - April 18 at 10:16 AM
European ADRs Edge Lower as Telecommunication Stocks Head SouthEuropean ADRs Edge Lower as Telecommunication Stocks Head South
www.nasdaq.com - April 3 at 5:58 PM
European ADRs Fractionally Higher as Pharmaceutical Stocks See Mixed FortunesEuropean ADRs Fractionally Higher as Pharmaceutical Stocks See Mixed Fortunes
www.nasdaq.com - March 28 at 10:15 AM
European ADRs Edge Lower as Manufacturers Head SouthEuropean ADRs Edge Lower as Manufacturers Head South
www.nasdaq.com - March 24 at 11:42 PM
7:42 am Midatech Pharma announces the successful initial scale-up and regulatory inspection of its state-of-the-art manufacturing site in Bilbao, Spain7:42 am Midatech Pharma announces the successful initial scale-up and regulatory inspection of its state-of-the-art manufacturing site in Bilbao, Spain
us.rd.yahoo.com - March 10 at 9:40 AM
European ADRs Fractionally Lower as Miners Head SouthEuropean ADRs Fractionally Lower as Miners Head South
www.nasdaq.com - March 9 at 8:33 AM
European ADRs Fractionally Lower Despite Banking GainsEuropean ADRs Fractionally Lower Despite Banking Gains
www.nasdaq.com - January 19 at 10:09 PM
European ADRs Move Higher in Thursday TradingEuropean ADRs Move Higher in Thursday Trading
www.nasdaq.com - December 29 at 6:40 PM
European ADRs Fractionally Higher as Pharma Stocks Gains Offset Mining LossesEuropean ADRs Fractionally Higher as Pharma Stocks' Gains Offset Mining Losses
www.nasdaq.com - December 23 at 11:52 PM
European ADRs Advance as Telecommunication Stocks Gain TractionEuropean ADRs Advance as Telecommunication Stocks Gain Traction
www.nasdaq.com - December 16 at 7:22 PM
European ADRs Rally as Telecommunications Stocks AdvanceEuropean ADRs Rally as Telecommunications Stocks Advance
www.nasdaq.com - December 13 at 7:05 PM

SEC Filings

Midatech Pharma (NASDAQ:MTP) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Midatech Pharma (NASDAQ:MTP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Midatech Pharma (NASDAQ MTP) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.